| [1] |
Terasaki PI, Ozawa M. Predicting kidney graft failure by HLA antibodies: a prospective trial[J].Am J Transplant, 2004, 4(3):438-443. doi: 10.1111/ajt.2004.4.issue-3
|
| [2] |
薛武军, 郑瑾. 重视组织配型和供者特异性抗体监测在肾移植中的重要作用[J]. 器官移植, 2014, 5(2):63-65. http://www.organtranspl.com/browse/detail/cat/29/id/216
Xue WJ, Zheng J. Important role of tissue matching and donor specific antibody monitoring in renal transplantation[J]. Organ Transplant, 2014, 5(2):63-65. http://www.organtranspl.com/browse/detail/cat/29/id/216
|
| [3] |
Lachmann N, Terasaki PI, Budde K, et al. Anti-human leukocyte antigen and donor-specificantibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts[J]. Transplantation, 2009, 87(10):1505-1513. doi: 10.1097/TP.0b013e3181a44206
|
| [4] |
Terasaki PI, Cai J. Human leukocyte antigen antibodies and chronic rejection: from associationto causation[J]. Transplantation, 2008, 86(3):377-383. doi: 10.1097/TP.0b013e31817c4cb8
|
| [5] |
Kohei N, Hirai T, Omoto K, et al. Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory period[J]. Am J Transplant, 2012, 12(2):469-476. doi: 10.1111/j.1600-6143.2011.03830.x
|
| [6] |
Everly MJ, Everly JJ, Susskind B, et al. Bortezomib provides effective therapy for antibody-and cell-mediated acute rejection[J]. Transplantation, 2008, 86(12):1754-1761. doi: 10.1097/TP.0b013e318190af83
|
| [7] |
Perry DK, Burns JM, Pollinger HS, et al. Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production[J]. Am J Transplant, 2009, 9(1):201-209. http://cn.bing.com/academic/profile?id=1506252195&encoded=0&v=paper_preview&mkt=zh-cn
|
| [8] |
Sberro-Soussan R, Zuber J, Suberbielle-Boissel C, et al. Bortezomib as the sole post-renaltransplantation desensitization agent does not decrease donor-specific anti-HLA antibodies[J].Am J Transplant, 2010, 10(3):681-686. doi: 10.1111/ajt.2010.10.issue-3
|
| [9] |
Woodle ES, Alloway RR, Girnita A. Proteasome inhibitor treatment of antibody-mediated allograft rejection[J]. Curr Opin Organ Transplant, 2011, 16(4):434-438. doi: 10.1097/MOT.0b013e328348c0e5
|
| [10] |
Oura T, Yamashita K, Suzuki T, et al. Long-term hepatic allograft acceptance based on CD40 blockade by ASKP1240 in nonhuman primates[J]. Am J Transplant, 2012, 12(7):1740-1754. doi: 10.1111/j.1600-6143.2012.04014.x
|
| [11] |
Tedder TF. CD19: a promising B cell target for rheumatoid arthritis[J]. Nat Rev Rheumatol, 2009, 5(10):572-577. doi: 10.1038/nrrheum.2009.184
|
| [12] |
Nagorsen D, Kufer P, Baeuerle PA, et al. Blinatumomab: a historical perspective[J]. Pharmacol Ther, 2012, 136(3):334-342. doi: 10.1016/j.pharmthera.2012.07.013
|
| [13] |
Stegall MD, Diwan T, Raghavaiah S, et al. Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients[J]. Am J Transplant, 2011, 11(11):2405-2413. doi: 10.1111/ajt.2011.11.issue-11
|
| [14] |
Biglarnia AR, Nilsson B, Nilsson T, et al. Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation[J]. Transpl Int, 2011, 24(8):e61-e66. doi: 10.1111/tri.2011.24.issue-8
|
| [15] |
Dalmasso AP, Platt JL. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor[J].Transplantation, 1993, 56(5):1171-1176. doi: 10.1097/00007890-199311000-00024
|
| [16] |
Terasaki PI, Ozawa M, Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival[J]. Am J Transplant, 2007, 7(2):408-415. doi: 10.1111/ajt.2007.7.issue-2
|
| [17] |
Fukami N, Ramachandran S, Saini D, et al. Antibodies to MHC class Ⅰ induce autoimmunity:role in the pathogenesis of chronic rejection[J]. J Immunol, 2009, 182(1):309-318. doi: 10.4049/jimmunol.182.1.309
|
| [18] |
Nath DS, Basha HI, Mohanakumar T. Antihuman leukocyte antigen antibody-induced autoimmunity:role in chronic rejection[J]. Curr Opin Organ Transplant, 2010, 15(1):16-20. doi: 10.1097/MOT.0b013e3283342780
|
| [19] |
Iwata T, Philipovskiy A, Fisher AJ, et al. Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction[J]. J Immunol, 2008, 181(8):5738-5747. doi: 10.4049/jimmunol.181.8.5738
|
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad: